HTA Policy Futures Team
Secretariat
Our Secretariat—delivered by ELC through sponsorship—underpins the delivery of HTA Policy Futures. Acting as the programme’s operational engine, it coordinates activity, enables collaboration, and maintains momentum across all workstreams. From shaping and delivering the Summit to managing outputs and stakeholder engagement, the Secretariat ensures the programme runs effectively and translates ideas into action.
View detailsStrategic Advisory Group
Our Strategic Advisory Group brings together senior leaders and experts to provide governance, challenge, and direction for HTA Policy Futures. They play a critical role in shaping the programme’s strategic trajectory—offering independent insight, holding the work to account, and ensuring it remains credible, relevant, and impactful in a rapidly evolving HTA landscape.
View detailsThought Leadership Group
Our Thought Leadership Group brings together respected and influential voices from across the UK and global life sciences community. Their expertise underpins the programme—bringing real-world experience, challenging constraints, and identifying opportunities to advance the goals of HTA Policy Futures.
View detailsSecretariat
Eric Low
Founder & CEO
Stephanie Callaghan
Senior Associate
Jonathan Simpson
Senior Associate
Strategic Advisory Group
Rachel Arrundale
Independent Consultant
Prof Carole Longson
Global Expert in Life Sciences and Health Technology Assessment
Jean Mossman
Independent Consultant
Dr Sean Tunis
Tufts Center for the Evaluation of Value and Risk in Health and Rubix Health
Thought Leadership Group
Dr Jane Adam
Independent Consultant
Prof Amanda Adler
Cambridge University Hospitals NHS Foundation Trust
Dave Allmond
HealthZeal
Gertjan Bartlema
Populus Bio
Prof Andy Briggs
The London School of Hygiene and Tropical Medicine
Dr Dima El-Sharkawi
The Royal Marsden NHS Trust
Dr Karen Facey
Independent Consultant
Karl Freemyer
Acumetis
Leslie Galloway
Ethical Medicines Industry Group
Brad Groves
National Institute for Health and Care Excellence
Victoria Hayes
Kyowa Kirin
Jess Hobart
UK Mastocytosis Support Group
Cathy Jarrold
Menarini Stemline
Prof Martin Kaiser
The Royal Marsden NHS Trust; The Institute of Cancer Research
Dr Jamail Kothari
Oxford University Hospitals NHS Trust
Heidi Livingstone
Independent Consultant
Joep Muijrers
Gilde Healthcare
Dr Dan Ollendorf
Institute for Clinical and Economic Review and Tufts Center for the Evaluation of Value and Risk in Health
Brian O’Rourke
Independent Consultant
Leeza Osipenko
Consilium Scientific
Nina Pinwill
Johnson & Johnson
Emma Roffe
Takeda
Anja Schiel
Norwegian Medical Products Agency
Ross Selby
ITF Pharma
Barry Stein
Colorectal Cancer Canada
Alison Strath
Scottish Government
Dr Gemma Taylor
University of Bristol
Keith Tolley
Tolley HTA
Andrew Walker
Salus Alba

